Edition:
United States

GTX Inc (GTXI.OQ)

GTXI.OQ on NASDAQ Stock Exchange Capital Market

0.58USD
25 Jul 2016
Change (% chg)

-- (--)
Prev Close
$0.58
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
15,229
52-wk High
$1.22
52-wk Low
$0.32

GTXI.OQ

Chart for GTXI.OQ

About

GTx, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other medical conditions. The Company is engaged in the development of selective androgen receptor modulators (SARMs). Its... (more)

Overall

Beta: 2.32
Market Cap(Mil.): $82.21
Shares Outstanding(Mil.): 141.75
Dividend: --
Yield (%): --

Financials

  GTXI.OQ Industry Sector
P/E (TTM): -- 41.28 37.71
EPS (TTM): -0.12 -- --
ROI: -71.78 -9.20 14.43
ROE: -71.82 -9.24 15.61

BRIEF-GTx reports Q1 earnings per share $0.01

* GTx provides corporate update and reports first quarter 2016 financial results

May 10 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.